Cargando…
Survival outcomes are associated with genomic instability in luminal breast cancers
Breast cancer is the leading cause of cancer related death among women. Breast cancers are generally diagnosed and treated based on clinical and histopathological features, along with subtype classification determined by the Prosigna Breast Cancer Prognostic Gene Signature Assay (also known as PAM50...
Autores principales: | King, Lydia, Flaus, Andrew, Holian, Emma, Golden, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857737/ https://www.ncbi.nlm.nih.gov/pubmed/33534788 http://dx.doi.org/10.1371/journal.pone.0245042 |
Ejemplares similares
-
GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal
por: King, Lydia, et al.
Publicado: (2022) -
Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas
por: Vincent-Salomon, Anne, et al.
Publicado: (2013) -
Loss of p27(kip1) increases genomic instability and induces radio-resistance in luminal breast cancer cells
por: Berton, Stefania, et al.
Publicado: (2017) -
Workshop on Instabilities in Luminous Early Type Stars
por: Lamers, Henny, et al.
Publicado: (1987) -
BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
por: Gupta, Ishita, et al.
Publicado: (2017)